Search Results

There are 769 results for: content related to: Cost-effectiveness of hematologic growth factors for anemia occurring during hepatitis C combination therapy

  1. Die Veränderung der Brutvogelfauna in zwei süddeutschen Dorfgemeindebereichen in den letzten fünf bzw. drei Jahrzehnten oder: verlorene Paradiese?

    Journal für Ornithologie

    Volume 144, Issue 4, October 2003, Pages: 385–410, Peter Berthold

    Version of Record online : 8 MAR 2004, DOI: 10.1111/j.1439-0361.2003.03046.x

  2. Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time

    Reviews in Medical Virology

    Volume 26, Issue 6, November 2016, Pages: 408–434, Lize Cuypers, Francesca Ceccherini-Silberstein, Kristel Van Laethem, Guangdi Li, Anne-Mieke Vandamme and Jürgen Kurt Rockstroh

    Version of Record online : 12 JUL 2016, DOI: 10.1002/rmv.1895

  3. Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 12, June 2016, Pages: 1276–1292, A. Majumdar, M. T. Kitson and S. K. Roberts

    Version of Record online : 18 APR 2016, DOI: 10.1111/apt.13633

  4. You have full text access to this OnlineOpen article
    Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection

    Liver International

    Jordan J. Feld, Ira M. Jacobson, Mark S. Sulkowski, Fred Poordad, Fernando Tatsch and Jean-Michel Pawlotsky

    Version of Record online : 29 SEP 2016, DOI: 10.1111/liv.13212

  5. Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases

    Hepatology

    Volume 64, Issue 4, October 2016, Pages: 1331–1342, Lorenzo Giovanni Mantovani, Paolo Angelo Cortesi and Mario Strazzabosco

    Version of Record online : 4 APR 2016, DOI: 10.1002/hep.28527

  6. You have full text access to this OnlineOpen article
    Cost-effectiveness of sofosbuvir for the treatment of chronic hepatitis C-infected patients

    Journal of Viral Hepatitis

    Volume 22, Issue 11, November 2015, Pages: 882–889, S. Cure, I. Guerra and G. Dusheiko

    Version of Record online : 7 APR 2015, DOI: 10.1111/jvh.12409

  7. You have free access to this content
    Hepatitis C virus therapy in liver transplant recipients: Response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis

    Liver Transplantation

    Volume 14, Issue 12, December 2008, Pages: 1766–1777, Bruno Roche, Mylene Sebagh, Maria Laura Canfora, Teresa Antonini, Anne-Marie Roque-Afonso, Valerie Delvart, Faouzi Saliba, Jean-Charles Duclos-Vallee, Denis Castaing and Didier Samuel

    Version of Record online : 24 NOV 2008, DOI: 10.1002/lt.21635

  8. You have free access to this content
    Meta-analysis: re-treatment of genotype I hepatitis C nonresponders and relapsers after failing interferon and ribavirin combination therapy

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 8, October 2010, Pages: 969–983, A. G. Singal, A. K. Waljee, M. Shiffman, B. R. Bacon and P. S. Schoenfeld

    Version of Record online : 15 AUG 2010, DOI: 10.1111/j.1365-2036.2010.04427.x

  9. You have free access to this content
    Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 6, September 2014, Pages: 657–675, S. Saab, S. C. Gordon, H. Park, M. Sulkowski, A. Ahmed and Z. Younossi

    Version of Record online : 28 JUL 2014, DOI: 10.1111/apt.12871

  10. You have free access to this content
    Interferon-free antiviral treatment of chronic hepatitis C in the transplant setting

    Transplant International

    Volume 28, Issue 9, September 2015, Pages: 1011–1024, Sandra Beinhardt, Markus Peck-Radosavljevic, Harald Hofer and Peter Ferenci

    Version of Record online : 23 APR 2015, DOI: 10.1111/tri.12577

  11. Treat chronic hepatitis C virus infection in decompensated cirrhosis – pre- or post-liver transplantation? the ironic conundrum in the era of effective and well-tolerated therapy

    Journal of Viral Hepatitis

    Volume 23, Issue 6, June 2016, Pages: 408–418, C. Bunchorntavakul and K. Rajender Reddy

    Version of Record online : 28 MAR 2016, DOI: 10.1111/jvh.12534

  12. You have free access to this content
    Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 25, Issue 10, May 2007, Pages: 1153–1162, M. SIMIN, J. BROK, D. STIMAC, C. GLUUD and L. L. GLUUD

    Version of Record online : 19 FEB 2007, DOI: 10.1111/j.1365-2036.2007.03294.x

  13. You have free access to this content
    Review article: predicting response in hepatitis C virus therapy

    Alimentary Pharmacology & Therapeutics

    Volume 23, Issue 8, April 2006, Pages: 1043–1054, U. MIHM, E. HERRMANN, C. SARRAZIN and S. ZEUZEM

    Version of Record online : 30 MAR 2006, DOI: 10.1111/j.1365-2036.2006.02863.x

  14. Current prospects for interferon-free treatment of hepatitis C in 2012

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 1, January 2013, Pages: 38–45, Catherine AM Stedman

    Version of Record online : 19 DEC 2012, DOI: 10.1111/jgh.12028

  15. You have free access to this content
    Hepatitis C genotype 4 therapy: increasing options and improving outcomes

    Liver International

    Volume 29, Issue s1, January 2009, Pages: 39–48, Sanaa M. Kamal

    Version of Record online : 21 JAN 2009, DOI: 10.1111/j.1478-3231.2008.01930.x

  16. Hepatitis B and C in liver transplantation: new strategies to combat the enemies

    Reviews in Medical Virology

    Volume 23, Issue 3, May 2013, Pages: 172–193, Susanne Beckebaum, Iyad Kabar and Vito R. Cicinnati

    Version of Record online : 13 DEC 2012, DOI: 10.1002/rmv.1734

  17. You have free access to this content
    Liver transplantation for hepatitis C

    Journal of Hepato-Biliary-Pancreatic Surgery

    Volume 13, Issue 5, September 2006, Pages: 382–392, Shigeru Marubashi, Keizo Dono, Atsushi Miyamoto, Yutaka Takeda, Hiroaki Nagano, Koji Umeshita and Morito Monden

    Version of Record online : 1 SEP 2006, DOI: 10.1007/s00534-005-1078-9

  18. Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 36, Issue 2, February 2016, Pages: 203–217, Paulina Deming, Michelle T. Martin, Juliana Chan, Thomas J. Dilworth, Rania El-Lababidi, Bryan L. Love, Rima A. Mohammad, Amy Nguyen, Linda M. Spooner and Suzanne B. Wortman

    Version of Record online : 5 FEB 2016, DOI: 10.1002/phar.1700

  19. Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons

    HIV Medicine

    Volume 17, Issue 2, February 2016, Pages: 83–88, L Ryom, C Boesecke, V Gisler, C Manzardo, JK Rockstroh, M Puoti, H Furrer, JM Miro, JM Gatell, A Pozniak, G Behrens, M Battegay, JD Lundgren and on behalf of the EACS Governing Board

    Version of Record online : 8 NOV 2015, DOI: 10.1111/hiv.12322

  20. You have free access to this content
    Current and emerging antiviral treatments for hepatitis C infection

    British Journal of Clinical Pharmacology

    Volume 75, Issue 4, April 2013, Pages: 931–943, Joseph S. Doyle, Esther Aspinall, Danny Liew, Alexander J. Thompson and Margaret E. Hellard

    Version of Record online : 15 MAR 2013, DOI: 10.1111/j.1365-2125.2012.04419.x